Hermetica Superfood Encyclopedia
The Short Answer
Phloridzin is a dihydrochalcone compound that selectively inhibits sodium-glucose co-transporters SGLT1 and SGLT2, blocking glucose absorption in the intestines and kidneys. This mechanism promotes glucose excretion through urine and may support blood sugar management.
CategoryNamed Bioactive Compounds
GroupCompound
Evidence LevelModerate
Primary Keywordphloridzin benefits
Synergy Pairings3
Phloridzin (phlorizin) — botanical close-up
Health Benefits
Origin & History
Natural habitat
Phloridzin is a dihydrochalcone flavonoid glucoside naturally found in apple tree bark and leaves (Malus domestica) and other Rosaceae family plants. It is extracted through crystallization as a dihydrate from water or synthesized via glucosylation of phloretin through NADPH-dependent pathways.
“No historical or traditional medicinal uses are documented in the available research. Phloridzin is primarily noted as a plant metabolite without references to traditional medicine systems.”Traditional Medicine
Scientific Research
No human clinical trials, RCTs, or meta-analyses have been conducted with phloridzin as a therapeutic agent. Available research focuses exclusively on preclinical models and mechanistic studies of SGLT transporter inhibition (referenced PMIDs 20980548, 34880492 describe SGLT mechanisms but not phloridzin trials).
Preparation & Dosage
Traditional preparation
No clinically studied dosage ranges are available as human trials are lacking. Preclinical research uses it as an SGLT inhibitor tool compound, but no standardized forms (extract, powder) or human dosing data exist. Consult a healthcare provider before starting any new supplement.
Nutritional Profile
Phloridzin (phlorizin) is a dihydrochalcone flavonoid compound, not a macronutrient source — it contains no meaningful protein, fat, fiber, or caloric content at physiologically relevant doses. Molecular formula: C21H24O10; molecular weight: 436.4 g/mol. It is a glycoside composed of phloretin (aglycone) linked to glucose via a beta-glycosidic bond. Naturally occurring concentrations: apple tree bark (up to 4–10% dry weight), apple leaves (~0.5–2% dry weight), apple roots (highest density, up to 10–12% dry weight), apple flesh and peel (trace amounts, 0.005–0.02 mg/g fresh weight). Crabapple species contain notably higher concentrations than commercial Malus domestica cultivars. As a bioactive compound, typical experimental doses range from 0.1–500 mg/kg body weight in preclinical models. Oral bioavailability is limited (~10–20% estimated) due to hydrolysis by intestinal lactase-phlorizin hydrolase (LPH) converting it to phloretin and glucose; phloretin itself is more readily absorbed. Phloretin plasma half-life approximately 2–4 hours in rodent models. No significant micronutrient content. Solubility: moderately soluble in water (~0.5 g/L at 25°C), better solubility in ethanol and methanol. Stability is pH-dependent with degradation accelerating above pH 8.
How It Works
Mechanism of Action
Phloridzin competitively inhibits sodium-glucose co-transporters SGLT1 in the small intestine and SGLT2 in the kidney proximal tubules, preventing glucose reabsorption. This blockade forces glucose excretion through urine (glycosuria) and reduces postprandial blood glucose levels. The compound also exhibits antioxidant activity through free radical scavenging mechanisms.
Clinical Evidence
Current evidence for phloridzin is limited to preclinical studies and mechanistic research in animal models. No human clinical trials have evaluated phloridzin supplementation for blood sugar management or other health outcomes. While the SGLT1/SGLT2 inhibition mechanism is well-established in laboratory studies, human efficacy data is absent. The compound's safety profile and effective dosing ranges in humans remain undetermined.
Safety & Interactions
Safety data for phloridzin supplementation in humans is lacking due to absence of clinical trials. Potential concerns include excessive glucose loss through urine, which could lead to dehydration or electrolyte imbalances. The compound may theoretically interact with diabetes medications, particularly SGLT2 inhibitors like empagliflozin, potentially causing additive glucose-lowering effects. Pregnant and breastfeeding women should avoid phloridzin due to insufficient safety data.
Synergy Stack
Hermetica Formulation Heuristic
Frequently Asked Questions
What foods contain phloridzin naturally?
Phloridzin is found primarily in apple peels, apple bark, and other parts of apple trees (Malus species). The compound is also present in smaller amounts in pears and some stone fruits, but apples remain the richest natural source.
How does phloridzin compare to prescription SGLT2 inhibitors?
Phloridzin shares the same mechanism as prescription SGLT2 inhibitors like empagliflozin but lacks clinical validation in humans. Unlike FDA-approved medications with established dosing and safety profiles, phloridzin has no human trial data to support its efficacy or safety.
What is the typical dosage of phloridzin supplements?
No established dosage recommendations exist for phloridzin supplements since human clinical trials have not been conducted. Preclinical studies have used varying doses, but translating these to safe and effective human dosages requires clinical research that is currently absent.
Can phloridzin cause low blood sugar in healthy people?
Phloridzin's mechanism of blocking glucose absorption could theoretically affect blood sugar levels in healthy individuals. However, without human studies, the actual risk of hypoglycemia or other glucose-related effects in non-diabetic people remains unknown and requires clinical investigation.
Is phloridzin the same as phlorizin?
Yes, phloridzin and phlorizin are the same compound with identical chemical structures and biological activities. The terms are used interchangeably in scientific literature, with phloridzin being the more commonly accepted spelling in modern research.
What does the current clinical evidence say about phloridzin's effectiveness in humans?
Most evidence for phloridzin comes from preclinical and animal studies showing glucose absorption inhibition and potential glycosuria promotion. Human clinical trials are largely absent, meaning its real-world efficacy and safety profile in people remain unestablished. Any claims about blood sugar management benefits should be considered preliminary until larger randomized controlled trials are completed in human populations.
Does phloridzin interact with diabetes medications or other common drugs?
Phloridzin's mechanism of blocking glucose reabsorption could theoretically potentiate the effects of antidiabetic medications, though human interaction data is sparse. Anyone taking prescription diabetes drugs, blood pressure medications, or medications affected by glucose levels should consult a healthcare provider before supplementing with phloridzin. The lack of clinical interaction studies means potential risks with common medications cannot be definitively ruled out.
Is phloridzin safe for people with kidney disease or impaired renal function?
Phloridzin's mechanism promotes glycosuria (glucose in urine) by inhibiting kidney reabsorption of glucose, which may stress already-compromised renal systems. People with chronic kidney disease, diabetic nephropathy, or reduced glomerular filtration rate should avoid phloridzin without explicit medical clearance. No safety studies have evaluated phloridzin use in populations with kidney dysfunction, making this a significant contraindication concern.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w phloridzin curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
